Developing a Method to Objectively Measure Opioid Analgesia

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

September 1, 2025

Study Completion Date

December 1, 2025

Conditions

Analgesics, Antipyretics and Anti-Inflammatory Drugs Causing Adverse Effects in Therapeutic Use

Trial Locations (1)

Children's National Health System, Washington D.C.

All Listed Sponsors

lead

Julia Finkel

OTHER

NCT03605966 - Developing a Method to Objectively Measure Opioid Analgesia | Biotech Hunter | Biotech Hunter